Life Technologies | Passività Correnti



Current Liabilities Cambiamento Data
Ardelyx USD 77.83M 7.33M 2024-12
Biogen USD 5.3B 231.4M 2025-03
Bristol-Myers Squibb USD 24.07B 296M 2025-03
Cipla INR 54.84B 291.6M 2025-03
Clal Biotechnology ILS 6.66M 3.75M 2023-12
Compugen USD 20.16M 7.6M 2024-12
CSL USD 4.95B 232M 2024-06
Galapagos EUR 437.04M 101.96M 2025-03
GlaxoSmithKline GBP 20.83B 866M 2025-03
Grifols EUR 2.16B 199.43M 2024-12
Life Technologies USD 14.97M 849K 2024-12
Novartis USD 28.69B 560M 2024-12
Roche Holding CHF 27.02B 424M 2024-12
United Therapeutics USD 721.5M 16.6M 2025-03



Life Technologies Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.